Table 4.
HLA DR and DQ alleles identified in the short and long persisting vaccinees.
Code | Reduction Ab titer (%) | DRB1 | DQB1 | |||||
---|---|---|---|---|---|---|---|---|
Short persisting | 26-INT-VAC | 0,83 | DRB1*11:04 | DRB1*15:01 | DQA1*01/DQB1*03:01 | DQA1*05/DQB1*03:01 | DQA1*01/DQB1*05:03 | DQA1*05/DQB1*05:03 |
21-INT-VAC | 0,79 | DRB1*01:03 | DRB1*04:04/23 | DQA1*03/DQB1*02:01 | DQA1*05/DQB1*02:01 | DQA1*03/DQB1*03:02 | DQA1*05/DQB1*03:02 | |
23-INT-VAC | 0,77 | DRB1*13:02 | DRB1*14:01P | DQA1*01/DQB1*02:01 | DQA1*05/DQB1*02:01 | DQA1*01/DQB1*06:02 | DQA1*05/DQB1*06:02 | |
46-INT-VAC | 0,76 | DRB1*03:01 | DRB1*11:01 | DQA1*05/DQB1*02:01 | DQA1*05/DQB1*03:01 | |||
24-INT-VAC | 0,76 | DRB1*13:03 | DRB1*15:01 | DQA1*03/DQB1*03:01 | DQA1*05/DQB1*03:01 | DQA1*03/DQB1*03:02 | DQA1*05/DQB1*03:02 | |
Long persisting | 8-INT-VAC | 0,00 | DRB1*01:01 | DRB1*11:03 | DQA1*01/DQB1*02:02 | DQA1*02/DQB1*02:02 | DQA1*01/DQB1*05:02 | DQA1*02/DQB1*05:02 |
40-INT-VAC | 0,00 | DRB1*14:01P | DRB1*15:02 | DQA1*05/DQB1*02:01 | DQA1*05/DQB1*03:01 | |||
15-INT-VAC | 0,00 | DRB1*11:04 | DRB1*13:02 | DQA1*01/DQB1*02:02 | DQA1*02/DQB1*02:02 | DQA1*01/DQB1*05:03 | DQA1*02/DQB1*05:03 | |
29-INT-VAC | 0,00 | DRB1*03:01 | DRB1*04:04/23 | DQA1*02/DQB1*03:01 | DQA1*05/DQB1*03:01 | DQA1*02/DQB1*03:03 | DQA1*05/DQB1*03:03 | |
7-INT-VAC | 0,00 | DRB1*13:02 | DRB1*11:01 | DQA1*01/DQB1*03:01 | DQA1*05/DQB1*03:01 | DQA1*05/DQB1*06:04 | DQA1*01/DQB1*06:04 |